Lysulin: Natural nutritional support to bring better health to people with diabetes and prediabetes

Authors

  • John Frederick Burd Lysulin, Inc.

DOI:

https://doi.org/10.31989/bchd.v2i6.600

Abstract

Obesity and type 2 diabetes, both worldwide epidemics, are drastic problems that can be ameliorated dramatically through the combination of lifestyle changes (especially diet and exercise) the treatment of drugs and nutritional supplements [1].  Lysulin is a patent-pending nutritional supplement that contains lysine, zinc and vitamin C [2]. Through double-blind placebo-controlled studies, it has been shown to help people with prediabetes [3] and type 2 diabetes [4] in promoting better glycemic control and lowering their HbA1c.

Historically, supplements have had a bad reputation due to aggressive marketing of unsubstantiated claims.  That being said, Lysulin is firmly grounded on a foundation of 25 years of research, development and clinical studies. These studies show the ingredients in Lysulin can lower blood glucose and glycated proteins – the cause of diabetes complications.  In addition, double-blind placebo-controlled studies found that Lysulin improves glycemic control in people with diabetes and may also slow or even halt the progression from prediabetes to type 2 diabetes [3,4].

Glucose is essential in providing the human body an energy source.  Glucose relies on the hormone, insulin, to enter our cells to provide the energy we need for everyday living. However, while everyone needs a certain amount of glucose for daily energy production, excessive glucose is dangerously toxic to the body (primarily as a result of protein glycation).  In addition, fructose (from High Fructose Corn Syrup) does not utilize insulin to enter the liver or our cells, and thus enters them easily and immediately turns into fat [5]. Poor diets, along with increased consumption of High Fructose Corn Syrup (HFCS), have lead to the high rates of obesity and diabetes that we see today. The pandemic of type 2 diabetes, which is expected to affect at least 250 million people worldwide by 2020 and 642 million by 2040 [6], is the result of diets high in carbohydrates, HFCS and sugar, along with the lack of commensurate exercise.  This lifestyle leads to insulin resistance, caused by the glycation of insulin and insulin receptors [7], which results in high concentrations of glucose in the bloodstream.  

The therapy for type 2 diabetes begins with attempts to control glucose through diet and exercise. If this fails, oral drugs are prescribed.  If these fail to show improvements in blood glucose levels, insulin injections are given. Over 30% of people with type 2 diabetes are using insulin injections to control their blood glucose levels [6]. There is vast literature documenting the role of nutraceuticals and functional foods in managing the alterations in metabolism and improving the health of people with chronic disease [8, 9].  To make up for the fact that important nutrients are lost during the processing of food, adding nutritional supplements to our daily routine, in addition to consuming a low-carbohydrate diet, can have profound benefits.   A well-balanced diet, along with exercise and the right nutritional supplements, can provide the foundation for a lifetime of well-being and good health.

Keywords: Diabetes, Nutritional Support, Lysulin, Lysine, Zinc, Vitamin V, HbA1c

Author Biography

  • John Frederick Burd, Lysulin, Inc.

    JOHN F. BURD, Ph.D. , Founder & CEO Lysulin, Inc.

    I was the Founder & CEO of DexCom, Inc., now the leader in continuous glucose monitoring. 

    In 2017 I founded Lysulin, Inc, in order to launch an all-natural, scientifically proven nutraceutical product proven to improve the health of people with diabetes.  The product, Lysulin was launched in January of 2018 and has been proven to work in double-blind placebo-controlled studies. 

    I am also the cofounder of Sabur Technology, Inc., where we are developing a new non-invasive continuous glucose monitoring technology.  I am also founder and CEO of Wonder Spray, llc.

    I have authored  over 40 publications and hold 35 issued patents.  I  graduated from Purdue University with a B.S. in Biochemistry, and earned an M.S. and Ph.D., also in Biochemistry, from the University of Wisconsin.  In 2010 I  was inducted into the American Association of Clinical Chemistry Hall of Fame and received the Ullman Prize for innovation in clinical chemistry

Published

2019-07-01

Issue

Section

Review Articles